US Edition
Health Care Stocks (IBB) Live: President Trump Promises Lower Drug Prices, Stocks Moving
- President Donald Trump signed an executive order on Monday directing drugmakers to lower U.S. Medicine prices by aligning them with other countries.
- The order follows prior attempts blocked by courts and introduces a “most-favoured nation” pricing policy aiming for 30% to 80% price cuts on popular Medicare drugs.
- The administration will set voluntary price targets within 30 days and consider regulatory actions if manufacturers fail to make significant progress within six months.
- Trump claimed prices would drop 59%, while experts and the pharmaceutical industry expressed uncertainty and concern about impacts and implementation clarity.
- Following the announcement, pharma stocks initially fell sharply but recovered as details emerged, while the order’s voluntary nature leaves pricing outcomes uncertain.
Insights by Ground AI
Does this summary seem wrong?
13 Articles
13 Articles
All
Left
Center
5
Right
2
Health Care Stocks (IBB) Live: President Trump Promises Lower Drug Prices, Stocks Moving
Live Updates Live Coverage Has Ended Pharmaceutical Stocks are Still Erasing Earlier Losses 11:44 am Following the initial shock from President Trump’s drug cost announcement, many of the top pharmaceutical stocks are still rebounding higher. Amgen (NASDAQ: AMGN), for example, is up more than 3.2%, or by $8.60 a share. AbbVie (NYSE: ABBV) is up just over 3.4%, or $6.35 a share. Bristol Myers Squibb (NYSE: BMY) is up just over 2.6%, or by $1.2…
·New York, United States
Read Full Article
Coverage Details
Total News Sources13
Leaning Left0Leaning Right2Center5Last UpdatedBias Distribution71% Center
Bias Distribution
- 71% of the sources are Center
71% Center
C 71%
R 29%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
